The James Webb Telescope's first photo of stars. (NASA)
WaveFront Sciences attracted interest from buyers as its scanning Shack-Hartmann grew more popular.
In 2007, the startup was acquired for $20 million by Advanced Medical Optics (AMO). Two years later, Abbott Laboratories, a medical device giant, acquired AMO—and, by extension, WaveFront Sciences—for $2.8 billion. In 2017, Johnson & Johnson purchased Abbott’s medical optics subsidiary, which included WaveFront. Then, in 2019, once Johnson & Johnson reportedly “ended development efforts” on WaveFront’s laser vision measurement device, members of WaveFront Sciences’ team broke off and created a brand new startup, called—familiarly enough—WaveFront Dynamics. That new company raised a $3 million Series A in August 2020.
Today, the Lasik world has built upon this sensor tech even further. It now offers even higher-resolution scans that analyze 1,257 microrefractions in the cornea—a 5x increase in data points from the initial scanning Shack-Hartmann system. That translates to treatments with a greater degree of customization, allowing people with more severe astigmatism, or with higher degrees of nearsightedness or farsightedness, to be candidates for surgery for the first time.
Thanks to recent advancements that have built upon the foundational sensor tech, Starr said Lasik is now moving on from its own Hubble phase and entering its Webb era—in other words, a time in which the field pushes the boundaries of what was once thought possible.
Tech Brew keeps business leaders up-to-date on the latest innovations, automation advances, policy shifts, and more, so they can make informed decisions about tech.